| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $9351 | $9404 | $9421 | $9046 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $769341 | $759534 | $801690 | $775558 |
| Current liabilities | ||||
| Accounts payable | $6569 | $11121 | $6458 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $34180 | $44581 | $34956 | |
| Long term debt | $67325 | $74971 | $75136 | $74191 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $716452 | $706294 | $749687 | $723857 |
| Shareholders' equity | ||||
| Retained earnings | $70536 | $47952 | $44997 | $45557 |
| Other shareholder equity | -$17647 | -$14635 | -$13499 | -$14793 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $67799 | $6447 | ||
| Short term investments | $8729 | $7979 | ||
| Net receivables | $932 | $1199 | ||
| Inventory | $1262 | $1584 | ||
| Total current assets | $191292 | $266350 | ||
| Long term investments | $103280 | $112186 | ||
| Property, plant & equipment | $9046 | $8737 | $7298 | $7672 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $775558 | $713140 | $662885 | $736176 |
| Current liabilities | ||||
| Accounts payable | $6458 | $5673 | $416946 | $404529 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $34956 | $9655 | $508081 | $587570 |
| Long term debt | $74191 | $55429 | $55763 | $66311 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $723857 | $666149 | $614125 | $686156 |
| Shareholders' equity | ||||
| Retained earnings | $45557 | $64422 | $35962 | $31813 |
| Other shareholder equity | -$14793 | -$17431 | -$16476 | -$14478 |
| Total shareholder equity | $43907 | $44548 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $39033 | $33239 | $18033 | $15488 |
| Cost of revenue | ||||
| Gross Profit | $18033 | $15488 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $9529 | $8744 | ||
| Total operating expenses | $9792 | $9634 | ||
| Operating income | $8241 | $5854 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $4003 | $3529 | $2207 | $1459 |
| Interest expense | ||||
| Net income | ||||
| Net income | $7675 | $6107 | $4653 | $1305 |
| Income (for common shares) | $4653 | $918 | ||
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$728 | -$374 | -$1419 | -$1247 |
| Financing activities | ||||
| Dividends paid | -$2245 | -$2808 | -$1857 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2023 | $1139 | -$1842 | -$376 |
| Effect of exchange rate | -$513 | $535 | -$357 | $535 |
| Change in cash and equivalents | -$30362 | $1108 | -$4339 | -$12896 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $4653 | $1305 | ||
| Operating activities | ||||
| Depreciation | $840 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $39349 | |||
| Investing activities | ||||
| Capital expenditures | -$632 | |||
| Investments | $245 | |||
| Total cash flows from investing | -$1419 | -$3911 | -$37 | |
| Financing activities | ||||
| Dividends paid | -$2808 | -$2185 | -$1065 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$395 | |||
| Total cash flows from financing | -$1842 | -$7563 | -$2069 | |
| Effect of exchange rate | -$357 | -$288 | -$4658 | |
| Change in cash and equivalents | -$4339 | $11957 | $32585 | |
|
Codelco Is Winning Over Investors on Signs of Copper Turnaround
Bloomberg · via Yahoo Finance
24 Feb 2025
|
|
Angola and Spain’s BBVA Said to Be in Talks for $1 Billion Loan
Bloomberg
24 Feb 2025
|
|
BBVA raises sustainable finance target to 700 billion euros
Reuters
23 Feb 2025
|
|
Strategic Financial Concepts LLC Makes New Investment in Banco Bilbao Vizcaya...
ETF DAILY NEWS
22 Feb 2025
|
|
Fitch rates several subsidiaries of BBVA and Santander By Investing.com
Investing.com
20 Feb 2025
|
|
European Bank Stocks Head for Best Winning Streak Since 1997
Bloomberg · via Yahoo Finance
20 Feb 2025
|
|
Blue Trust Inc. Has $209,000 Position in Banco Bilbao Vizcaya Argentaria, S.A....
ETF DAILY NEWS
20 Feb 2025
|
|
BBVA issues 1 billion euro 12-year tier 2 bond By Investing.com
Investing.com
18 Feb 2025
|
|
Garrigues and Uría Menéndez Lawyers Top Spain's M&A Charts in 2024
Law.com
18 Feb 2025
|
|
Is Banco Bilbao Vizcaya Argentaria (BBVA) One of the Best Performing Bank Stocks...
Insider Monkey · via Yahoo Finance
17 Feb 2025
|
| Market cap | $114.93B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 5.74B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |